Sustained Survival after Cord Blood Transplantation without Serotherapy in Pediatric Congenital Disorders

Puntos clave

• Sustained survival after cord blood transplantation highlights the potential of hematopoietic stem cells for treating congenital disorders.
• Overall survival rates improved notably without the use of serotherapy, emphasizing a promising approach for pediatric patients.
• This analysis involved the assessment of pediatric patients who underwent cord blood transplantation, focusing on clinical outcomes.
• Findings imply that avoiding serotherapy may enhance treatment effectiveness in specific pediatric congenital conditions.